ArticleEmerging infectious diseases2016
Waterborne Elizabethkingia meningoseptica in Adult Critical Care.
Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mortality Risk and Antibiotic Therapy for Patients with Infections Caused byMedicina (Kaunas, Lithuania) · 2024Pooled it
- Review
- Late-Onset Sepsis and Meningitis Caused byInfection and drug resistance · 2026Article
- Large-scale genomic analysis of Elizabethkingia anophelis.BMC genomics · 2024Article
- Identification of novel Tet(X6)-Tet(X2) recombinant variant inFrontiers in microbiology · 2024Article
- Synergistic Antimicrobial Effects of Ibuprofen Combined with Standard-of-Care Antibiotics against Cystic Fibrosis Pathogens.Biomedicines · 2023Article
- Review on infection control strategies to minimize outbreaks of the emerging pathogen Elizabethkingia anophelis.Antimicrobial resistance and infection control · 2023Review
- Emerging Prevalence and Clinical Features ofInfection and drug resistance · 2023Article
- Natural occurrences and characterization ofFrontiers in cellular and infection microbiology · 2023Article
- Multi-Drug-Resistant Elizabethkingia meningoseptica: A Rare Cause of Late-Onset Sepsis in a Preterm Neonate.Cureus · 2023Article
- Mutant Prevention Concentrations of Ciprofloxacin and Levofloxacin and Target Gene Mutations of Fluoroquinolones in Elizabethkingia anophelis.Antimicrobial agents and chemotherapy · 2022Article
- Antimicrobial Resistance and Comparative Genomic Analysis ofAntibiotics (Basel, Switzerland) · 2022Article
- Genomic analysis ofCurrent research in microbial sciences · 2022Article
- Single Cell Raman Spectroscopy Deuterium Isotope Probing for Rapid Antimicrobial Susceptibility Test ofFrontiers in microbiology · 2022Article
- Epidemiological, clinical, and laboratory features of patients infected withFrontiers in public health · 2022Article
- Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin againstAntibiotics (Basel, Switzerland) · 2021Article
- Isolation ofFrontiers in microbiology · 2021Article
- Clinical profile, susceptibility patterns, speciation and follow up of infections byNew microbes and new infections · 2020Article
- Comparative Genomics and Antimicrobial Resistance Profiling ofJournal of clinical microbiology · 2020Article
- Molecular Characteristics and Antimicrobial Susceptibility Profiles ofInfection and drug resistance · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Elizabethkingia meningoseptica is an infrequent colonizer of the respiratory tract; its pathogenicity is uncertain. In the context of a 22-month outbreak of E. meningoseptica acquisition affecting 30 patients in a London, UK, critical care unit (3% attack rate) we derived a measure of attributable morbidity and determined whether E. meningoseptica is an emerging nosocomial pathogen. We found monomicrobial E. meningoseptica acquisition (n = 13) to have an attributable morbidity rate of 54% (systemic inflammatory response syndrome ≥2, rising C-reactive protein, new radiographic changes), suggesting that E. meningoseptica is a pathogen. Epidemiologic and molecular evidence showed acquisition was water-source-associated in critical care but identified numerous other E. meningoseptica strains, indicating more widespread distribution than previously considered. Analysis of changes in gram-negative speciation rates across a wider London hospital network suggests this outbreak, and possibly other recently reported outbreaks, might reflect improved diagnostics and that E. meningoseptica thus is a pseudo-emerging pathogen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.